| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2021-09-11 08:49:30 UTC |
|---|
| Update Date | 2021-09-26 23:03:28 UTC |
|---|
| HMDB ID | HMDB0251466 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole |
|---|
| Description | 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole, also known as 4',6-bis(2'imidazolinyl-4',5'-H)-2-phenylindole or diimidazolinophenylindol, belongs to the class of organic compounds known as 2-phenylindoles. These are indoles substituted at the 2-position with a phenyl group. Based on a literature review very few articles have been published on 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole. This compound has been identified in human blood as reported by (PMID: 31557052 ). 6-(4,5-dihydro-1h-imidazol-2-yl)-2-(4-(4,5-dihydro-1h-imidazol-2-yl)phenyl)-1h-indole is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
|---|
| Structure | C1CN=C(N1)C1=CC=C(C=C1)C1=CC2=C(N1)C=C(C=C2)C1=NCCN1 InChI=1S/C20H19N5/c1-3-14(19-21-7-8-22-19)4-2-13(1)17-11-15-5-6-16(12-18(15)25-17)20-23-9-10-24-20/h1-6,11-12,25H,7-10H2,(H,21,22)(H,23,24) |
|---|
| Synonyms | | Value | Source |
|---|
| 4',6-Bis(2'imidazolinyl-4',5'-H)-2-phenylindole | HMDB | | Diimidazolinophenylindol | HMDB |
|
|---|
| Chemical Formula | C20H19N5 |
|---|
| Average Molecular Weight | 329.407 |
|---|
| Monoisotopic Molecular Weight | 329.164045632 |
|---|
| IUPAC Name | 6-(4,5-dihydro-1H-imidazol-2-yl)-2-[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]-1H-indole |
|---|
| Traditional Name | 6-(4,5-dihydro-1H-imidazol-2-yl)-2-[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]-1H-indole |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | C1CN=C(N1)C1=CC=C(C=C1)C1=CC2=C(N1)C=C(C=C2)C1=NCCN1 |
|---|
| InChI Identifier | InChI=1S/C20H19N5/c1-3-14(19-21-7-8-22-19)4-2-13(1)17-11-15-5-6-16(12-18(15)25-17)20-23-9-10-24-20/h1-6,11-12,25H,7-10H2,(H,21,22)(H,23,24) |
|---|
| InChI Key | DOETVZCFKJCYJV-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as 2-phenylindoles. These are indoles substituted at the 2-position with a phenyl group. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Indoles and derivatives |
|---|
| Sub Class | Indoles |
|---|
| Direct Parent | 2-phenylindoles |
|---|
| Alternative Parents | |
|---|
| Substituents | - 2-phenylindole
- 2-phenylpyrrole
- Monocyclic benzene moiety
- Imidolactam
- Substituted pyrrole
- Benzenoid
- 2-imidazoline
- Heteroaromatic compound
- Pyrrole
- Amidine
- Carboxylic acid amidine
- Azacycle
- Organic 1,3-dipolar compound
- Carboximidamide
- Propargyl-type 1,3-dipolar organic compound
- Hydrocarbon derivative
- Organic nitrogen compound
- Organopnictogen compound
- Organonitrogen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Predicted by Siyang on May 30, 2022 | 11.6776 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 4.16 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 824.8 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 301.7 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 153.6 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 200.8 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 175.6 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 356.7 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 285.3 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 642.6 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 741.4 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 361.3 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 989.5 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 273.2 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 272.7 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 521.6 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 435.1 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 51.8 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole,1TMS,isomer #1 | C[Si](C)(C)N1CCN=C1C1=CC=C(C2=CC3=CC=C(C4=NCCN4)C=C3[NH]2)C=C1 | 3720.1 | Semi standard non polar | 33892256 | | 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole,1TMS,isomer #1 | C[Si](C)(C)N1CCN=C1C1=CC=C(C2=CC3=CC=C(C4=NCCN4)C=C3[NH]2)C=C1 | 3730.3 | Standard non polar | 33892256 | | 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole,1TMS,isomer #1 | C[Si](C)(C)N1CCN=C1C1=CC=C(C2=CC3=CC=C(C4=NCCN4)C=C3[NH]2)C=C1 | 5321.3 | Standard polar | 33892256 | | 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole,1TMS,isomer #2 | C[Si](C)(C)N1C(C2=CC=C(C3=NCCN3)C=C2)=CC2=CC=C(C3=NCCN3)C=C21 | 3728.0 | Semi standard non polar | 33892256 | | 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole,1TMS,isomer #2 | C[Si](C)(C)N1C(C2=CC=C(C3=NCCN3)C=C2)=CC2=CC=C(C3=NCCN3)C=C21 | 3723.6 | Standard non polar | 33892256 | | 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole,1TMS,isomer #2 | C[Si](C)(C)N1C(C2=CC=C(C3=NCCN3)C=C2)=CC2=CC=C(C3=NCCN3)C=C21 | 5575.2 | Standard polar | 33892256 | | 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole,1TMS,isomer #3 | C[Si](C)(C)N1CCN=C1C1=CC=C2C=C(C3=CC=C(C4=NCCN4)C=C3)[NH]C2=C1 | 3723.6 | Semi standard non polar | 33892256 | | 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole,1TMS,isomer #3 | C[Si](C)(C)N1CCN=C1C1=CC=C2C=C(C3=CC=C(C4=NCCN4)C=C3)[NH]C2=C1 | 3724.6 | Standard non polar | 33892256 | | 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole,1TMS,isomer #3 | C[Si](C)(C)N1CCN=C1C1=CC=C2C=C(C3=CC=C(C4=NCCN4)C=C3)[NH]C2=C1 | 5316.7 | Standard polar | 33892256 | | 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole,2TMS,isomer #1 | C[Si](C)(C)N1CCN=C1C1=CC=C(C2=CC3=CC=C(C4=NCCN4[Si](C)(C)C)C=C3[NH]2)C=C1 | 3750.2 | Semi standard non polar | 33892256 | | 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole,2TMS,isomer #1 | C[Si](C)(C)N1CCN=C1C1=CC=C(C2=CC3=CC=C(C4=NCCN4[Si](C)(C)C)C=C3[NH]2)C=C1 | 3720.1 | Standard non polar | 33892256 | | 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole,2TMS,isomer #1 | C[Si](C)(C)N1CCN=C1C1=CC=C(C2=CC3=CC=C(C4=NCCN4[Si](C)(C)C)C=C3[NH]2)C=C1 | 4921.3 | Standard polar | 33892256 | | 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole,2TMS,isomer #2 | C[Si](C)(C)N1CCN=C1C1=CC=C(C2=CC3=CC=C(C4=NCCN4)C=C3N2[Si](C)(C)C)C=C1 | 3729.9 | Semi standard non polar | 33892256 | | 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole,2TMS,isomer #2 | C[Si](C)(C)N1CCN=C1C1=CC=C(C2=CC3=CC=C(C4=NCCN4)C=C3N2[Si](C)(C)C)C=C1 | 3692.3 | Standard non polar | 33892256 | | 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole,2TMS,isomer #2 | C[Si](C)(C)N1CCN=C1C1=CC=C(C2=CC3=CC=C(C4=NCCN4)C=C3N2[Si](C)(C)C)C=C1 | 5208.4 | Standard polar | 33892256 | | 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole,2TMS,isomer #3 | C[Si](C)(C)N1CCN=C1C1=CC=C2C=C(C3=CC=C(C4=NCCN4)C=C3)N([Si](C)(C)C)C2=C1 | 3751.0 | Semi standard non polar | 33892256 | | 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole,2TMS,isomer #3 | C[Si](C)(C)N1CCN=C1C1=CC=C2C=C(C3=CC=C(C4=NCCN4)C=C3)N([Si](C)(C)C)C2=C1 | 3689.0 | Standard non polar | 33892256 | | 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole,2TMS,isomer #3 | C[Si](C)(C)N1CCN=C1C1=CC=C2C=C(C3=CC=C(C4=NCCN4)C=C3)N([Si](C)(C)C)C2=C1 | 5202.8 | Standard polar | 33892256 | | 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole,3TMS,isomer #1 | C[Si](C)(C)N1CCN=C1C1=CC=C(C2=CC3=CC=C(C4=NCCN4[Si](C)(C)C)C=C3N2[Si](C)(C)C)C=C1 | 3748.4 | Semi standard non polar | 33892256 | | 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole,3TMS,isomer #1 | C[Si](C)(C)N1CCN=C1C1=CC=C(C2=CC3=CC=C(C4=NCCN4[Si](C)(C)C)C=C3N2[Si](C)(C)C)C=C1 | 3680.9 | Standard non polar | 33892256 | | 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole,3TMS,isomer #1 | C[Si](C)(C)N1CCN=C1C1=CC=C(C2=CC3=CC=C(C4=NCCN4[Si](C)(C)C)C=C3N2[Si](C)(C)C)C=C1 | 4731.9 | Standard polar | 33892256 | | 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1CCN=C1C1=CC=C(C2=CC3=CC=C(C4=NCCN4)C=C3[NH]2)C=C1 | 3956.9 | Semi standard non polar | 33892256 | | 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1CCN=C1C1=CC=C(C2=CC3=CC=C(C4=NCCN4)C=C3[NH]2)C=C1 | 3937.3 | Standard non polar | 33892256 | | 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1CCN=C1C1=CC=C(C2=CC3=CC=C(C4=NCCN4)C=C3[NH]2)C=C1 | 5420.4 | Standard polar | 33892256 | | 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C(C2=CC=C(C3=NCCN3)C=C2)=CC2=CC=C(C3=NCCN3)C=C21 | 3926.1 | Semi standard non polar | 33892256 | | 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C(C2=CC=C(C3=NCCN3)C=C2)=CC2=CC=C(C3=NCCN3)C=C21 | 3948.4 | Standard non polar | 33892256 | | 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C(C2=CC=C(C3=NCCN3)C=C2)=CC2=CC=C(C3=NCCN3)C=C21 | 5593.2 | Standard polar | 33892256 | | 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N1CCN=C1C1=CC=C2C=C(C3=CC=C(C4=NCCN4)C=C3)[NH]C2=C1 | 3956.2 | Semi standard non polar | 33892256 | | 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N1CCN=C1C1=CC=C2C=C(C3=CC=C(C4=NCCN4)C=C3)[NH]C2=C1 | 3927.4 | Standard non polar | 33892256 | | 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N1CCN=C1C1=CC=C2C=C(C3=CC=C(C4=NCCN4)C=C3)[NH]C2=C1 | 5413.3 | Standard polar | 33892256 | | 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1CCN=C1C1=CC=C(C2=CC3=CC=C(C4=NCCN4[Si](C)(C)C(C)(C)C)C=C3[NH]2)C=C1 | 4157.9 | Semi standard non polar | 33892256 | | 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1CCN=C1C1=CC=C(C2=CC3=CC=C(C4=NCCN4[Si](C)(C)C(C)(C)C)C=C3[NH]2)C=C1 | 4135.4 | Standard non polar | 33892256 | | 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1CCN=C1C1=CC=C(C2=CC3=CC=C(C4=NCCN4[Si](C)(C)C(C)(C)C)C=C3[NH]2)C=C1 | 5003.9 | Standard polar | 33892256 | | 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1CCN=C1C1=CC=C(C2=CC3=CC=C(C4=NCCN4)C=C3N2[Si](C)(C)C(C)(C)C)C=C1 | 4160.3 | Semi standard non polar | 33892256 | | 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1CCN=C1C1=CC=C(C2=CC3=CC=C(C4=NCCN4)C=C3N2[Si](C)(C)C(C)(C)C)C=C1 | 4124.8 | Standard non polar | 33892256 | | 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1CCN=C1C1=CC=C(C2=CC3=CC=C(C4=NCCN4)C=C3N2[Si](C)(C)C(C)(C)C)C=C1 | 5251.6 | Standard polar | 33892256 | | 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N1CCN=C1C1=CC=C2C=C(C3=CC=C(C4=NCCN4)C=C3)N([Si](C)(C)C(C)(C)C)C2=C1 | 4183.9 | Semi standard non polar | 33892256 | | 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N1CCN=C1C1=CC=C2C=C(C3=CC=C(C4=NCCN4)C=C3)N([Si](C)(C)C(C)(C)C)C2=C1 | 4115.3 | Standard non polar | 33892256 | | 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N1CCN=C1C1=CC=C2C=C(C3=CC=C(C4=NCCN4)C=C3)N([Si](C)(C)C(C)(C)C)C2=C1 | 5249.3 | Standard polar | 33892256 | | 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1CCN=C1C1=CC=C(C2=CC3=CC=C(C4=NCCN4[Si](C)(C)C(C)(C)C)C=C3N2[Si](C)(C)C(C)(C)C)C=C1 | 4304.9 | Semi standard non polar | 33892256 | | 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1CCN=C1C1=CC=C(C2=CC3=CC=C(C4=NCCN4[Si](C)(C)C(C)(C)C)C=C3N2[Si](C)(C)C(C)(C)C)C=C1 | 4332.7 | Standard non polar | 33892256 | | 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1CCN=C1C1=CC=C(C2=CC3=CC=C(C4=NCCN4[Si](C)(C)C(C)(C)C)C=C3N2[Si](C)(C)C(C)(C)C)C=C1 | 4786.0 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole GC-MS (Non-derivatized) - 70eV, Positive | splash10-0nmi-0393000000-24d813e7b5ff35ae2213 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole 10V, Positive-QTOF | splash10-001i-0009000000-dd30e71c9caac9d17a02 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole 20V, Positive-QTOF | splash10-001i-0009000000-7833f401a753ac8b3195 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole 40V, Positive-QTOF | splash10-01p9-0094000000-ab2526b01b6e8be04416 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole 10V, Negative-QTOF | splash10-004i-0009000000-67712f8ec5b10c3b3fa3 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole 20V, Negative-QTOF | splash10-004i-0019000000-bf0e8aea32d83dc75c89 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole 40V, Negative-QTOF | splash10-0imr-0097000000-18f5dd8912d187dc1068 | 2021-10-12 | Wishart Lab | View Spectrum |
|
|---|